Flame structure in aluminized wide-distribution AP composite propellants

Flame structure in wide-distribution ammonium-perchlorate (AP), hydroxyl-terminated-polybutadiene (HTPB) binder, aluminum (Al) composite propellants is studied using 2-D laminates with oxygenated binder. Very fine (2-μm) AP (FAP) is used to produce fuel-rich, matrix propellant (oxygenated binder) with a FAP/binder ratio of 75/25. Coarse AP (CAP) is simulated by pressed AP lamina. A flame-structure regime map for the CAP/oxy-fuel matrix interaction flame is generated as a function of oxy-fuel matrix thickness and pressure using high-speed video imaging analysis. The flame structure is found to be similar to that previously described using UV and IR imaging for non-aluminized laminates with split (diffusion) flame structure at high pressures (P) and low fuel thicknesses (L) and merged (partially premixed) flame structure for low P and L. The CAP/matrix flame regime boundary is shown to be correlated by Peclet number, indicating the relevance of conserved-scalar (Shvab-Zeldovich) theory with simple, global AP/hydrocarbon chemistry to describe the CAP/matrix diffusion-flame stoichiometry. Other findings include a slight stabilizing effect of Al on the 1-D premixed combustion of the marginally stable fuel-rich matrix. Also, when burning in 2-D laminates assisted slightly by the CAP/matrix interaction flame, the 75/25 matrix is found to burn flat (perpendicular to regression direction) even in the split-flame regime, in contrast to lower FAP/binder ratio matrices, which protrude into the gas-phase. Findings such as these are essential for developing a fundamental understanding of and truly predictive simulation capability for combustion of wide-distribution AP propellants, including plateau, mesa and bi-plateau propellants.     

Derivation of HLA-A11/Kb transgenic mice: functional CTL repertoire and recognition of human A11-restricted CTL epitopes

Transgenic mice expressing chimeric human (alpha1 and alpha2 HLA-A11 domains) and murine (alpha3, transmembrane, and cytoplasmic H-2Kb domains) class I molecules were derived. These mice were used as a model system to study the immunogenicity of human CTL epitopes and also to examine the aspects of Ag processing differences of mice vs man. Immunization of these mice with seven known HLA-A11-restricted CTL epitopes emulsified in IFA resulted in vigorous specific CTL responses. A larger panel of 45 A11-binding peptides was used to examine the relationship between immunogenicity in the HLA-A11/Kb transgenic mice and HLA-A11 binding capacity. Twenty-one of 28 (75%) peptides with high binding affinities (50% inhibitory concentration (IC50), 2-50 nM) and 7 of 13 (54%) intermediate binding peptides (IC50, 50-500 nM range) were immunogenic. In parallel, 19 of these peptides were used for in vitro primary immunizations of PBMC derived from HLA-A11 healthy human donors. It was found that 8 of 8 peptides that were able to elicit CTL in primary human in vitro cultures were also immunogenic in HLA-A11/Kb mice. Finally, HLA-A11/Kb transgenic mice were found to generate an A11/Kb restricted CTL response following immunization with influenza virus A/PR/8/34, suggesting that, at least to some extent, A11 epitopes are generated by transgenic mice as a result of natural in vivo processing and presentation.     

Anesthesia case of the month. Dystocia, cesarean section and acupuncture resuscitation of newborn kittens

OBJECTIVE: To assess the results of laparoscopic splenectomy as a treatment for immune thrombocytopenic purpura (ITP). MATERIAL AND METHODS: We conducted a retrospective study of all patients who underwent laparoscopic splenectomy for ITP at our institution between August 1992 and May 1997. RESULTS: Of 27 patients who underwent attempted laparoscopic splenectomy for ITP at our institution during the study period, 26 had completion of the procedure without conversion to an open splenectomy. The median postoperative hospital stay was 1.5 days, and no postoperative deaths occurred. In one patient, pancreatitis developed postoperatively. In four patients, splenectomy failed--two initially and two subsequently--and reinstitution of medical therapy was necessary. The other patients have remained free of medication, and 19 patients have platelet counts greater than 100 x 10(9)/L. The 3-year actuarial success rate was 81.5%. Response to corticosteroid therapy preoperatively may be an indicator of success of splenectomy. CONCLUSION: Laparoscopic splenectomy is safe and allows prompt recovery. Long-term response rates are similar to those achieved with open splenectomy.     

Novel antitumor 2-cyanoaziridine-1-carboxamides

A set of 20 2-cyanoaziridine-1-carboxamides was synthesized from 2-cyanoaziridine and appropriate isocyanates. These compounds were active against a variety of solid and hematological tumor cells in culture, including strains resistant to doxorubicin and mitoxantrone. Their potencies in these assays correlated with the lipophilicity of substituents. The N-phenyl derivative was more potent and equally effective to imexon, a cyclized 2-cyanoaziridine-1-carboxamide of clinical interest, against cloned fresh human tumors.     

The role of state policies and programs in buffering the effects of poverty on children's immunization receipt

OBJECTIVES: This study assessed the influence of public policies on the immunization status of 2-year old children in the United States. METHODS: Up-to-dateness for the primary immunization series was assessed in a national sample of 8100 children from the 1988 National Maternal and Infant Health Survey and its 1991 Longitudinal Follow-Up. RESULTS: Documented immunization rates of this sample were 33% for poor children and 44% for others. More widespread Medicated coverage was associated with greater likelihood of up-to-dateness among poor children. Up-to-dateness was more likely for poor children with public rather than private sources of routine pediatric care, but all children living in states where most immunizations were delivered in the public sector were less likely to be up to date. Poor children in state with partial vaccine replacement programs were less likely to be up to date than those in free-market purchase states. CONCLUSIONS: While state policies can enhance immunization delivery for poor children, heavy reliance on public sector immunization does not ensure timely receipt of vaccines. Public- and private-sector collaboration is necessary to protect children from vaccine-preventable diseases.